Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.57 is 26% above its 4-year average of -2.13, near the high end of its 4-year range (-2.62–-1.41).
4.32% below its 12-month average of -1.50.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.54.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.57
EARNINGS PER SHARE (EPS) AVG TTM
-1.50
EARNINGS PER SHARE (EPS) AVG 3Y
-2.00
EARNINGS PER SHARE (EPS) AVG 5Y
-2.13
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.32%
CURRENT VS 3Y AVG
+21.70%
CURRENT VS 5Y AVG
+26.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Nkarta, Inc.
Market Cap
$169.92M
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.50
3Y Avg
-2.00
5Y Avg
-2.13
Market Cap
$169.88M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.56
3Y Avg
-2.45
5Y Avg
-2.61
Market Cap
$170.58M
Earnings Per Share (EPS)
-0.83
TTM Avg
0.02
3Y Avg
0.22
5Y Avg
0.10
Market Cap
$172.49M
Earnings Per Share (EPS)
-27.00
TTM Avg
-15.00
3Y Avg
-27.00
5Y Avg
-32.85
Market Cap
$173.23M
Earnings Per Share (EPS)
-0.46
TTM Avg
-0.40
3Y Avg
-0.54
5Y Avg
-0.73
Market Cap
$166.26M
Earnings Per Share (EPS)
0.23
TTM Avg
-0.41
3Y Avg
-0.62
5Y Avg
-0.44
Market Cap
$173.63M
Earnings Per Share (EPS)
-2.80
TTM Avg
-1.25
3Y Avg
-14.14
5Y Avg
-22.50
Market Cap
$173.86M
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.39
3Y Avg
-0.36
5Y Avg
-0.55
Market Cap
$163.69M
Earnings Per Share (EPS)
-2.63
TTM Avg
-1.75
3Y Avg
-1.74
5Y Avg
-1.61
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $169.92M | -1.57 | -1.50 | -2.00 | -2.13 |
| MediWound Ltd. (MDWD)vs › | $169.88M | -1.60 | -2.56 | -2.45 | -2.61 |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.58M | -0.83 | 0.02 | 0.22 | 0.10 |
| Cue Biopharma, Inc. (CUE)vs › | $172.49M | -27.00 | -15.00 | -27.00 | -32.85 |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -0.46 | -0.40 | -0.54 | -0.73 |
| OptimizeRx Corp. (OPRX)vs › | $166.26M | 0.23 | -0.41 | -0.62 | -0.44 |
| Precision BioSciences, Inc. (DTIL)vs › | $173.63M | -2.80 | -1.25 | -14.14 | -22.50 |
| Compass Therapeutics, Inc. (CMPX)vs › | $173.86M | -0.41 | -0.39 | -0.36 | -0.55 |
| Quanterix Corporation (QTRX)vs › | $163.69M | -2.63 | -1.75 | -1.74 | -1.61 |
| PepGen Inc. (PEPG)vs › | $162.20M | -1.50 | -2.49 | -3.17 | -2.41 |
Trailing EPS (TTM)
$-1.57
Forward EPS (Est.)
$-1.67
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.41 |
| 2024-12-31 | -1.60 |
| 2023-12-31 | -2.40 |
| 2022-12-31 | -2.61 |
| 2021-12-31 | -2.62 |
| 2019-12-31 | -2.55 |
| 2018-12-31 | -0.01 |
